K-Clip® Launches First Commercial Implants in China: A Milestone for Transcatheter Tricuspid Valve Repair
H&H Healthcare
R&D and Producer of Interventional Medical Devices for Heart Disease
April 22, 2025, HuiHe Healthcare K-Clip®The Transcatheter Tricuspid Annuloplasty System Officially Begins the First Commercial Implantation After Launch!
The team of Academician Ge Junbo from Zhongshan Hospital Affiliated to Fudan University、The team of Academician Wang Jian'an from the Second Affiliated Hospital of Zhejiang University School of MedicineAndProfessor Song Guangyuan from Beijing Anzhen Hospital, Capital Medical UniversityCarryProfessor Lin YixianProfessors from Four Top Cardiac Centers Successfully Apply on the Same Day in Three LocationsK-Clip®The first implantation after the listing was successfully completed, officially kicking off the commercialization of transcatheter tricuspid valve therapy in China!
Zhongshan Hospital, Fudan University
Academician Ge Junbo, Professors Zhou Daxin, Pan Wenzhi, and Zhang Xiaochun's Team
The Second Affiliated Hospital of Zhejiang University School of Medicine
Academician Jian'an Wang, Professor Xianbao Liu Team
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Beijing Anzhen Hospital, Capital Medical University
Professor Song Guangyuan's Team, Professor Lin Yixian
K-Clip independently developed by HuiHe Healthcare®The transcatheter tricuspid annuloplasty system, K-Clip, demonstrated outstanding performance in the first batch of commercial implants in China, earning unanimous praise from clinical experts for its excellent clinical outcomes.®The clinical application fills the technical gap in the field of tricuspid valve interventional treatment in China, providing a revolutionary treatment option for patients with severe tricuspid regurgitation.In the future, with the popularization of technology and the accumulation of evidence-based experience, it is expected to combine atrial fibrillation ablation and left heart valve intervention to explore a "one-stop" solution for complex cardiac lesions.
K-Clip® Transcatheter Tricuspid Annuloplasty System
1. Through vascular puncture approach, minimal damage, outer diameter of the sheath is 18Fr.
2. Simple operation, all completed on the atrial surface, with a short learning curve.
3. All operational steps before dissociation are reversible, and the surgical outcome is controllable.
4. Directly acts on the annulus without affecting subsequent treatments.